Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-t6hkb Total loading time: 0 Render date: 2024-07-12T02:48:18.275Z Has data issue: false hasContentIssue false

3 - Clinical recognition

Published online by Cambridge University Press:  31 July 2009

Golder N. Wilson
Affiliation:
Department of Pediatrics, Texas Tech University
E. Steve Roach
Affiliation:
Wake Forest University, North Carolina
Van S. Miller
Affiliation:
University of Texas Southwestern Medical Center, Dallas
Get access

Summary

Introduction

Equally powerful for generalists or specialists, with simple principles available for every field of medicine, genetics is fundamental to diagnosis and prevention. Neurocutaneous syndromes illustrate the value of the genetic approach, since they often exhibit Mendelian inheritance. They also illustrate the value of pattern recognition, since the association of congenital brain and skin anomalies often predicts a broad spectrum of disease. This chapter presents basic principles of genetics and dysmorphology, illustrating the use of these principles in approaching the spectrum of neurocutaneous diseases.

Key to the genetic approach are resources that provide information on rare diseases. Paramount among these is the catalogue of genetic diseases originally assembled by Victor McKusick (Online Mendelian Inheritance in Man, 2002). Each disease thought to exhibit Mendelian inheritance and, more recently, each characterized human gene or protein has been assigned a 6-digit number. McKusick numbers will be provided for the genetic and neurocutaneous diseases mentioned in this chapter, allowing easy reference at the on-line website. Management of the more common disorders is discussed by Wilson & Cooley (2000).

The genetic approach in medicine

While individual genetic disorders may be rare, the effect of genetic factors on disease is widespread. Coronary artery disease is an example where a focus on extreme disease (young people with heart attacks) identified a gene involved in cholesterol uptake. Once autosomal dominant hypercholesterolemia was characterized by mutations in the low density lipoprotein receptor, cholesterol testing became an indicator of genetic risk that led to diet or drug therapy.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alliance of Genetic Support Groups (2000). (www.medhelp.org/geneticalliance/)
Biesecker, L. G., Happle, R., Mulliken, J. B. et al. (1999). Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. American Journal of Medical Genetics, 84: 389–3953.0.CO;2-O>CrossRefGoogle ScholarPubMed
Chen, F., Kishida, T., Yao, M. et al. (1995). Germline mutations in the von Hippel–Lindau disease tumor suppressor gene: correlations with phenotype. Human Mutation, 5: 66–75CrossRefGoogle ScholarPubMed
Cohen, M. M. Jr. (1990). Bannayan–Riley–Ruvalcaba syndrome: renaming three formerly recognized syndromes as one etiologic entity. (Letter). American Journal of Medical Genetics, 35: 291CrossRefGoogle ScholarPubMed
Cohen, M. M. Jr. (1995). Understanding Proteus syndrome, unmasking the Elephant Man, and stemming elephant fever. Neurofibromatosis, 1: 260–280, 1988Google Scholar
Committee on Genetics. (1995). Health supervision for children with neurofibromatosis. Pediatrics, 96: 368–371
Dobyns, W. B., Michels, V. V., Groover, R. V. et al. (1987). Familial cavernous malformations of the central nervous system and retina. Annals of Neurology, 21: 578–583CrossRefGoogle ScholarPubMed
Giroux, J-M. & Barbeau, A. (1972). Erythrokeratodermia with ataxia. Archives of Dermatology, 106: 183–188CrossRefGoogle ScholarPubMed
Gomez, M. R. (1979). Cerebellotrigeminal and focal dermal dysplasia: a newly recognized neurocutaneous syndrome. Brain Development, 1: 253–256CrossRefGoogle ScholarPubMed
Gorlin, R. J. (1987). Nevoid basal-cell carcinoma syndrome. Medicine, 66: 98–113, 1987CrossRefGoogle ScholarPubMed
Guttmacher, A. E., Marchuk, D. A. & White, R. I. Jr. (1995). Hereditary hemorrhagic telangiectasia. New England Journal of Medicine, 333: 918–924CrossRefGoogle ScholarPubMed
Hall, J. G. (1988). Somatic mosaicism: Observations related to clinical genetics. American Journal of Human Genetics, 43: 355–363Google ScholarPubMed
Hanssen, A. M. N. & Fryns, J. P. (1995). Cowden syndrome. Journal of Medical Genetics, 32: 117–119CrossRefGoogle ScholarPubMed
Happle, R. (1998). Incontinentia pigmenti versus hypomelanosis of Ito: the whys and wherefores of a confusing issue. (Letter). American Journal of Medical Genetics, 79: 64–653.0.CO;2-K>CrossRefGoogle ScholarPubMed
Hurst, J. & Baraitser, M. (1988). Hereditary neurocutaneous angiomatous malformations: autosomal dominant inheritance in two families. Clinical Genetics, 33: 44–48, 1988CrossRefGoogle ScholarPubMed
Johnson, D. W., Berg, J. N., Baldwin, M. A. et al. (1996a). Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nature Genetics, 13: 189–195CrossRefGoogle Scholar
Johnson, R. L., Rothman, A. L., Xie, J. et al. (1996b). Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science, 272: 1668–1671CrossRefGoogle Scholar
Jones, K. L. (1997). Smith's Recognizable Patterns of Human Malformation, 5th edn. Philadelphia: W. B. Saunders
Kaplan, A. M., Itabashi, H. H., Hanelin, L. G. & Lu, A. T. (1975). Neurocutaneous melanosis with malignant leptomeningeal melanoma. Archives of Neurolology, 32: 669–671CrossRefGoogle ScholarPubMed
Karsdorp, N., Elderson, A., Wittebol-Post, D. et al. (1994). Von Hippel–Lindau disease: new strategies in early detection and treatment. American Journal of Medicine, 97: 158–168CrossRefGoogle ScholarPubMed
Kastan, M. B., Zhan, Q., El-Deiry, W. S. et al. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia–telangiectasia. Cell, 71: 587–597CrossRefGoogle ScholarPubMed
King, M. D., Gummer, C. L. & Stephenson, J. B. P. (1984). Trichothiodystrophy–neurotrichocutaneous syndrome of Pollitt: a report of two unrelated cases. Journal of Medical Genetics, 21: 286–289CrossRefGoogle ScholarPubMed
Laberge-le Couteulx, S., Jung, H. H., Labauge, P. et al. (1999). Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nature Genetics, 23: 189–193CrossRefGoogle ScholarPubMed
Liaw, D., Marsh, D. J., Li, J. et al. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genetics, 16: 64–67CrossRefGoogle ScholarPubMed
MacCollin, M., Mohney, T., Trofatter, J., Wertelecki, W., Ramesh, V. & Gusella, J. (1993). DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree. Journal of the American Medical Association, 270: 2316–2320CrossRefGoogle Scholar
McAllister, K. A., Grogg, K. M., Johnson, D. W. et al. (1994). Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genetics, 8: 345–351CrossRefGoogle ScholarPubMed
Marden, P. M. & Venters, H. D. (1966). A new neurocutaneous syndrome. American Journal of Diseases of Children, 112: 79Google ScholarPubMed
Marsh, D. J., Kum, J. B., Lunetta, K. L. et al. (1999). PTEN mutation spectrum and genotype–phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Human Molecular Genetics, 8: 1461–1472CrossRefGoogle ScholarPubMed
Mehregan, A. H. & Pinkus, H. (1965). Life history of organoid nevi. Archives of Dermatology, 91: 574–588CrossRefGoogle ScholarPubMed
Munke, M., Kruse, K., Goos, M., Ropers, H. H. & Tolksdorf, M. (1983). Genetic heterogeneity of the ichthyosis, hypogonadism, mental retardation, and epilepsy syndrome: clinical and biochemical investigations on two patients with Rud syndrome and review of the literature. European Journal of Pediatrics, 141: 8–13CrossRefGoogle ScholarPubMed
Niida, Y., Lawrence-Smith, N., Banwell, A. et al. (1999). Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Human Mutation, 14: 412–4223.0.CO;2-K>CrossRefGoogle ScholarPubMed
Nowaczyk, M. J. M., Mernagh, J. R., Boureois, J. M., Thompson, P. J. & Jurriaans, E. (2000). Antenatal and postnatal findings in encephalocraniocutaneous lipomatosis. American Journal of Medical Genetics, 91: 261–2663.0.CO;2-S>CrossRefGoogle ScholarPubMed
Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), (2002). World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/
Riccardi, V. M., (1981). von Recklinghausen neurofibromatosis. New England Journal of Medicine, 305: 1617–1626CrossRefGoogle ScholarPubMed
Rigamonti, D., Hadley, M. N., Drayer, B. P. et al. (1988). Cerebral cavernous malformations: incidence and familial occurrence. New England Journal of Medicine, 319: 343–347CrossRefGoogle ScholarPubMed
Roach, E. S., Smith, M., Huttenlocher, P., Bhat, M., Alcorn, D. & Hawley, L., (1992). Diagnostic criteria: tuberous sclerosis complex. Journal of Child Neurology, 7: 221–224CrossRefGoogle ScholarPubMed
Saul, R. A. & Stevenson, R. E. (1986). Are Bannayan and Ruvalcaba– Myhre–Smith syndrome discrete entities? Proceedings of the Greenwood Genetics Center, 5: 3–7Google Scholar
Snead, O. C. III, Acker, J. D. & Morawetz, R. (1979). Familial arteriovenous malformation. Annals of Neurology, 5: 585–587CrossRefGoogle ScholarPubMed
Sujansky, E. & Conradi, S. (1995). Outcome of Sturge–Weber syndrome in 52 adults. American Journal of Medical Genetics, 57: 35–45CrossRefGoogle ScholarPubMed
Thomas, I. T., Frias, J. L., Cantu, E. S., Lafer, C. Z., Flannery, D. B. & Graham, J. G. Jr. (1989). Association of pigmentary anomalies with chromosomal and genetic mosaicism and chimerism. American Journal of Medical Genetics, 45: 193–205Google ScholarPubMed
Wilson, G. N., (2000). Clinical Genetics. A Short Course. New York: John Wiley
Wilson, G. N. & Cooley W. C. (2000). Preventive Management of Congenital Anomalies and Syndromes. Cambridge: Cambridge University Press
Xu, G., O'Connell, P., Viskochil, D. et al. (1990). The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell, 62: 599–608CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Clinical recognition
  • Edited by E. Steve Roach, Wake Forest University, North Carolina, Van S. Miller, University of Texas Southwestern Medical Center, Dallas
  • Book: Neurocutaneous Disorders
  • Online publication: 31 July 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545054.005
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Clinical recognition
  • Edited by E. Steve Roach, Wake Forest University, North Carolina, Van S. Miller, University of Texas Southwestern Medical Center, Dallas
  • Book: Neurocutaneous Disorders
  • Online publication: 31 July 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545054.005
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Clinical recognition
  • Edited by E. Steve Roach, Wake Forest University, North Carolina, Van S. Miller, University of Texas Southwestern Medical Center, Dallas
  • Book: Neurocutaneous Disorders
  • Online publication: 31 July 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545054.005
Available formats
×